CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy. [electronic resource]
Producer: 20081125Description: 3982-8 p. digitalISSN:- 1528-0020
- Adolescent
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD20 -- biosynthesis
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Asparaginase -- administration & dosage
- Child
- Child, Preschool
- Daunorubicin -- administration & dosage
- Female
- Gene Expression Regulation, Leukemic -- drug effects
- Humans
- Infant
- Male
- Neoplasm, Residual
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Prednisone -- administration & dosage
- Recurrence
- Rituximab
- Up-Regulation -- drug effects
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.